[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-333941-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-333941-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","research-progress-on-human-papillomavirus-negative-cervical-cancer-a-review","Research progress on human papillomavirus-negative cervical cancer - A review","","Cervical cancer is the fourth most common cancer in women worldwide. While most cases are linked to human papillomavirus (HPV) infection, a smaller subset occurs independently of HPV, often with false-negative testing. Improving detection accuracy is therefore essential for clarifying HPV-negative cervical cancer pathogenesis and patient prognosis. Current evidence suggests distinct mechanisms involving immune microenvironment features, tumor gene mutations, and selected long noncoding RNAs. This review summarizes the latest research on causes, mechanisms, pathology, and clinical characteristics to support better diagnosis, treatment, and outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/research-progress-on-human-papillomavirus-negative-cervical-cancer-a-review/333941/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/research-progress-on-human-papillomavirus-negative-cervical-cancer-a-review/333941.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is accurate detection important for studying HPV-negative cervical cancer?","Question",{"text":63,"@type":64},"Current testing can produce false negatives, so improving detection accuracy is crucial to correctly identify HPV-negative cases and study their disease mechanisms and prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What factors are suggested to be involved in HPV-negative cervical cancer pathogenesis?",{"text":68,"@type":64},"Research indicates involvement of the immune microenvironment, certain tumor gene mutations (e.g., TP53, PIK3CA, CDKN2A), and some long noncoding RNAs, although the exact mechanism is not fully clear.",{"name":70,"@type":61,"acceptedAnswer":71},"How can HPV-negative tumor misclassification be addressed?",{"text":72,"@type":64},"Misclassification may occur when other cancers involving the cervix metastasize. Additional differentiation can be performed using immunohistochemical staining of tumor and stroma, based on marker expression patterns.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},333941,1790013188,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","®  \n Narrative Review   \nResearch progress on human papillomavirus-negative cervical cancer  \nA review  \nNing Shao, MDa ,*  \n\n| Abstract\u003Cbr>Cervical cancer is the fourth most common cancer in women worldwide. The vast majority of cervical cancers are associated with human papillomavirus (HPV) infection, but a small proportion of cervical cancers occur independently of HPV infection, with different subtypes having varying rates of occurrence. Despite the presence of false negatives in current testing, improving the accuracy of detection is crucial for studying the pathogenesis of HPV-negative cervical cancer and improving the prognosis of these patients. Existing research suggests that HPV-negative cervical cancer has a different pathogenesis from HPV-positive cervical cancer, although the exact mechanism is not yet clear. It is currently believed to be associated with the immune microenvironment, certain tumor gene mutations, and some long noncoding RNAs. This article provides an overview of the latest research progress on HPV-negative cervical cancer, including possible reasons, pathogenesis, pathological features, and clinical characteristics, aiming to provide new insights for diagnosis, treatment, and prognosis improvement. |\n| --- |\n| Abbreviations: CCC = clear cell adenocarcinoma, CEA = carcinoembryonic antigen, DES = estrogen hormone diethylstilbestrol , ER = estrogen receptor, GCA = gastric-type adenocarcinoma, HIF-1α = hypoxia-inducible factor 1 alpha, HPV = human papillomavirus, HPVA = HPV-related endocervical adenocarcinoma, IECC criteria = The International Endocervical Adenocarcinoma Criteria and Classification, lncRNA ANCR = long noncoding RNA Antidifferentiation ncRNA, lncRNAs = long noncoding RNAs, NHPVA = non-HPV-related endocervical adenocarcinoma, PR = progesterone receptor, SCC = squamous cell carcinoma, YAP = Yes-associated protein. |\n| Keywords: cervical cancer, HPV-independent, molecular genetics |\n\n1. Introduction  \nCervical cancer is the fourth most common cancer in women worldwide, accounting for 6.5% of all cancers. The mortality rate of cervical cancer patients ranks fourth among all cancers, accounting for 7.5% of all female cancer-related deaths.[1] Over 90% of cervical cancers are caused by human papillomavirus (HPV) infection.[2] In the United States, due to inadequate screening, an estimated 14,000 people are diagnosed with cervical cancer each year, with over 4000 deaths attributed to cervical cancer. The majority of global cases are in low- and middle-income countries.[3] Therefore, it is essential to not only increase HPV vaccination and effective screening but also develop treatment methods for women already diagnosed with the disease.[3,4] The prevalence of HPV-positive cervical cancer significantly increased from 85.9% to 92.9% between 1990 and 2010.[5] This increase is closely related to the improvement and widespread adoption of cervical cancer screening technologies and advancements in pathological tissue diagnosis. However, there are still 3% to 8% of cervical cancers that are truly HPV-negative.[6–8]  \nCompared to HPV-positive cervical cancer patients, HPVnegative cervical ADC is more common. Due to the difficulty of  \nThe authors declared no conflict of interest.  \nThe datasets generated during and/or analyzed during the current study are publicly available.  \na Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.  \n* Correspondence: Ning Shao, Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (e-mail: [15010299121@163.com](15010299121@163.com)).  \nearly screening, diagnosis is often made in the advanced stage with lymph node involvement, resulting in a poorer prognosis. The molecular etiology of HPV-negative ADC is not yet clear, but some studies suggest that mutations in TP53, PIK3CA, and CDKN2A may be associated with its pathogenesis.[9–1","cbCaiuWnnyYTxrH6","https://ap.wps.com/l/cbCaiuWnnyYTxrH6","pdf",503578,"English","# Introduction\n# HPV-negative cervical cancer possible causes\n## Tumor misclassification","[{\"question\":\"Why is accurate detection important for studying HPV-negative cervical cancer?\",\"answer\":\"Current testing can produce false negatives, so improving detection accuracy is crucial to correctly identify HPV-negative cases and study their disease mechanisms and prognosis.\"},{\"question\":\"What factors are suggested to be involved in HPV-negative cervical cancer pathogenesis?\",\"answer\":\"Research indicates involvement of the immune microenvironment, certain tumor gene mutations (e.g., TP53, PIK3CA, CDKN2A), and some long noncoding RNAs, although the exact mechanism is not fully clear.\"},{\"question\":\"How can HPV-negative tumor misclassification be addressed?\",\"answer\":\"Misclassification may occur when other cancers involving the cervix metastasize. Additional differentiation can be performed using immunohistochemical staining of tumor and stroma, based on marker expression patterns.\"}]","Research progress on human papillomavirus-negative cervical cancer - A review | PDF",1790004711]